About the resource

About

Gentle Clearing 18 is an independent information resource. Civic Kestrel publishes plain‑language summaries and organizational guides about research topics, including an independent reference about Ibogaine Trials In The USA: The National Picture, and explains trial pathways, regulation, evidence, risks, and unresolved questions.

Our mission is to foreground independence and evidence: we aim to describe how research and policy are evolving without promoting services or treatments.

Close-up detail view related to United States ibogaine research — textured laboratory surface and instruments — Photograph illustrating close-up research detail related to our topic.

Our editorial approach

We curate and synthesize publicly available records, peer-reviewed literature, trial registries, and official statements. Where appropriate, we reference registry entries and government guidance rather than individual anecdotes. For example, standard trial registration practices are well described by ClinicalTrials.gov and associated policies at the U.S. National Library of Medicine (clinicaltrials.gov).

We favor primary sources and established institutions when describing regulatory or procedural points; when contextualizing safety, we cite authoritative public health resources such as the Centers for Disease Control and Prevention (cdc.gov).

How information is sourced and vetted

We triangulate data from multiple kinds of records: trial registries, peer‑reviewed studies, institutional guidance, and public agency notices. Assertions in our writing are accompanied by links to primary sources where possible; when summarizing a body of evidence we indicate uncertainty and gaps rather than overstate conclusions. For registry entries and trial identifiers we consult authoritative listings such as ClinicalTrials.gov and institutional repositories at leading universities (harvard.edu) when appropriate.

We also review methodology summaries so readers can judge how generalizable findings are; methodological guidance from recognized research bodies helps anchor those descriptions.

Editorial checks

Independence: we are not affiliated with providers or clinics;
Evidence first: preference for primary sources and registries;
Plain language: translate technical details without oversimplifying;
Safety context: highlight known risks and regulatory status;
Transparent sourcing: link to original documents where available.

Who this is for

This site serves people seeking a clear, cautious understanding of U.S. ibogaine trials and related policy questions, including researchers, clinicians seeking context, and members of the public evaluating the evidence. We do not provide clinical recommendations or referrals.

Practical note

For information about providers and service descriptions sometimes referenced on this site, we link to third‑party informational directories such as ibogaine suppliers and community resources; see examples included in our explanatory prose, for instance an informational supplier listing at ibogainesupplement.com.

Independent by design

Civic Kestrel is an independent resource on the evolving U.S. landscape for ibogaine and noribogaine research. We are not a clinic, medical provider, or licensed treatment center; our content is not medical or legal advice. Readers seeking medical care should consult licensed professionals and official guidance.

Frequently asked

Do you provide medical advice?: No. Gentle Clearing 18 provides information only and does not replace clinical consultation.
How can I verify a trial record?: Trial identifiers and registry entries are typically verifiable on registries such as ClinicalTrials.gov; when we cite a registry entry we link directly to it or to an institutional page that hosts the record (clinicaltrials.gov).
How is the site funded?: Funding and support are disclosed on request; the site's editorial decisions are guided by the values above and by transparency about sources.

Stay oriented

If you're following national research or seeking structured summaries, our services page explains the kinds of informational support we publish.

Explore services